仙琚制药(002332) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥1,224,968,165.51, representing a year-on-year increase of 4.34%[9] - The net profit attributable to shareholders for the same period was ¥198,120,672.95, up 6.98% compared to the previous year[9] - The net profit after deducting non-recurring gains and losses was ¥188,329,142.28, reflecting a 5.95% increase year-on-year[9] - The company's basic earnings per share for Q3 2022 was ¥0.2003, an increase of 6.99% year-on-year[9] - Total operating revenue for the current period reached ¥3,452,994,013.86, an increase from ¥3,317,191,595.25 in the previous period, representing a growth of approximately 4.1%[30] - Operating profit for the current period was ¥658,236,093.00, compared to ¥558,228,356.10 in the previous period, indicating an increase of about 17.9%[33] - Net profit attributable to shareholders of the parent company was ¥529,212,330.11, up from ¥459,227,911.54 in the previous period, reflecting a growth of approximately 15.2%[36] - The total comprehensive income for the current period was ¥508,762,429.65, compared to ¥425,629,559.55 in the previous period, marking an increase of around 19.5%[36] - Basic and diluted earnings per share for the current period were both ¥0.5350, up from ¥0.4642 in the previous period, reflecting an increase of approximately 15.3%[36] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥6,717,131,761.80, showing a slight decrease of 0.09% from the end of the previous year[9] - The equity attributable to shareholders increased to ¥5,186,090,053.98, marking a growth of 7.39% compared to the end of the previous year[9] - As of September 30, 2022, the total current assets amounted to approximately CNY 3.50 billion, a slight decrease from CNY 3.55 billion at the beginning of the year, representing a decline of about 1.5%[24] - Total assets as of September 30, 2022, were CNY 6.72 billion, slightly down from CNY 6.73 billion at the beginning of the year, a decrease of about 0.1%[26] - Total liabilities decreased to CNY 1.48 billion from CNY 1.78 billion, representing a reduction of approximately 16.9%[26] - The company's fixed assets were valued at CNY 1.44 billion, down from CNY 1.62 billion, indicating a decrease of about 10.7%[26] - The company reported a total equity of CNY 5.24 billion, which remained stable compared to the previous period[26] Cash Flow - Cash flow from operating activities for the year-to-date was ¥366,266,769.53, which decreased by 25.14% year-on-year[9] - Cash flow from operating activities generated a net amount of ¥366,266,769.53, down from ¥489,272,169.41 in the previous period, a decrease of about 25.1%[37] - Investment cash outflow totaled $427,545,973.52, an increase from $176,802,076.94 in the previous period[40] - Net cash flow from investment activities was $29,341,038.61, recovering from a negative $137,418,121.03 last year[40] - Financing cash inflow amounted to $179,110,211.79, down from $335,680,641.75 in the previous period[40] - Cash outflow from financing activities was $647,520,967.79, slightly decreased from $661,714,463.78 last year[40] - Net cash flow from financing activities was -$468,410,756.00, worsening from -$326,033,822.03 in the previous period[40] - The net decrease in cash and cash equivalents was -$55,104,094.26, contrasting with an increase of $14,755,885.90 in the previous period[40] - The ending balance of cash and cash equivalents was $1,080,090,603.11, down from $1,213,586,617.63 last year[40] Shareholder Information - There were no significant changes in the top ten shareholders' equity structure, with the largest shareholder holding 21.55% of the shares[21] Research and Development - Research and development expenses for the current period were ¥150,824,651.11, slightly decreased from ¥156,896,426.83 in the previous period, a reduction of approximately 3.9%[30] Market Strategy - The company is focusing on expanding its market presence and developing new products, although specific figures were not disclosed in the report[28] Other Financial Metrics - The weighted average return on net assets was 3.88%, a decrease of 0.10% compared to the previous year[9] - The company experienced a 113.29% increase in prepayments compared to the beginning of the year, amounting to an increase of ¥25,518,000[14] - The company reported a decrease in other comprehensive income after tax of ¥-23,969,658.40 compared to ¥-35,415,822.61 in the previous period, indicating an improvement[36]